دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Editorial Board
doi : 10.1016/S1542-3565(23)00546-3
Volume 21, Issue 10, September 2023, Pages A11-A12
Table of Contents
doi : 10.1016/S1542-3565(23)00547-5
Volume 21, Issue 10, September 2023, Pages A13-A16
Elsewhere in the AGA Journals
doi : 10.1016/S1542-3565(23)00548-7
Volume 21, Issue 10, September 2023, Pages A25-A27
Diffuse Esophageal Glycogenic Acanthosis: Not Always Incidental
doi : 10.1016/j.cgh.2023.02.020
Volume 21, Issue 10, September 2023, Pages A31-A32
Splenic Arteriovenous Fistula Coexisting With Spontaneous Splenorenal Shunt in a Cirrhotic Patient
Guofeng Liu,* Xiaoze Wang,* and Xuefeng Luo
doi : 10.1016/j.cgh.2023.03.007
Volume 21, Issue 10, September 2023, Page A33
Endoscopic Nikolsky Sign
Samuel Pan, 1 Mahmoud A. Ali, 2 and Anish Vinit Patel 3
doi : 10.1016/j.cgh.2023.03.048
Volume 21, Issue 10, September 2023, Pages A35-A36
Blue Notes
CHARLES J. KAHI, MD, MS, AGAF
doi : 10.1016/j.cgh.2023.06.009
Volume 21, Issue 10, September 2023, Pages 2441-2442
Research Considerations in Digestive and Liver Disease in Transgender and Gender-Diverse Populations
doi : 10.1016/j.cgh.2023.06.008
Volume 21, Issue 10, September 2023, Pages 2443-2449.e2
The Importance of Professional Societies as Academic Homes
doi : 10.1016/j.cgh.2023.05.005
Volume 21, Issue 10, September 2023, Pages 2450-2456
Improving Upper Gastrointestinal Endoscopy Quality
Fateh Bazerbachi, 1 Prabhleen Chahal, 2 and Aasma Shaukat
doi : 10.1016/j.cgh.2023.04.002
Volume 21, Issue 10, September 2023, Pages 2457-2461
Potential Value of Biomarker-Based Approaches for Evaluation and Management of Costly Functional Gastrointestinal Diseases
Michael Camilleri and Joelle BouSaba
doi : 10.1016/j.cgh.2023.04.030
Volume 21, Issue 10, September 2023, Pages 2462-2472
AGA Clinical Practice Update on Management of Ostomies: Commentary
Traci L. Hedrick, 1 Alexis Sherman, 2 Shirley Cohen-Mekelburg, 3,4 and Jill K. J. Gaidos
doi : 10.1016/j.cgh.2023.04.035
Volume 21, Issue 10, September 2023, Pages 2473-2477
Ultra-processed Foods and Risk of Crohn’s Disease: How Much is Too Much?
JESSICA A. FITZPATRICK EMMA P. HALMOS PETER R. GIBSON PRISCILA P. MACHADO
doi : 10.1016/j.cgh.2023.03.009
Volume 21, Issue 10, September 2023, Pages 2478-2480
Metabolic Health and Outcomes in Fatty Liver: Does a Name Change Matter?
LEON A. ADAMS
doi : 10.1016/j.cgh.2022.11.028
Volume 21, Issue 10, September 2023, Pages 2481-2482
Food Processing and Risk of Inflammatory Bowel Disease: AÂ Systematic Review and Meta-Analysis
Neeraj Narula, 1 Nicole H. Chang, 1 Danah Mohammad, 1 Emily C. L. Wong, 1 Ashwin N. Ananthakrishnan,2 Simon S. M. Chan,3 Franck Carbonnel,4 and Antoine Meyer 4
doi : 10.1016/j.cgh.2023.01.012
Volume 21, Issue 10, September 2023, Pages 2483-2495.e1
Mortality and Liver-Related Events in Lean Versus Non-Lean Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis
Jane Ha, 1, * Sun Young Yim, 2, * and Raffi Karagozian
doi : 10.1016/j.cgh.2022.11.019
Volume 21, Issue 10, September 2023, Pages 2496-2507.e5
Dietary Interventions for the Treatment of Inflammatory Bowel Diseases: An Updated Systematic Review and Meta-analysis
Berkeley N. Limketkai, 1,2 Gala Godoy-Brewer, 3 Alyssa M. Parian, 2 Shaya Noorian, 4 Mahesh Krishna, 2 Neha D. Shah, 5 Jacob White, 6 and Gerard E. Mullin
doi : 10.1016/j.cgh.2022.11.026
Volume 21, Issue 10, September 2023, Pages 2508-2525.e10
Monitoring Patients With Eosinophilic Esophagitis in Routine Clinical Practice - International Expert Recommendations
Ulrike von Arnim, 1, * Luc Biedermann, 2, * Seema S. Aceves,3 Peter A. Bonis, 4 Margaret H. Collins, 5 Evan S. Dellon, 6 Glenn T. Furuta, 7,8 Nirmala Gonsalves, 9 Sandeep Gupta, 10 Ikuo Hirano, 11 Alfredo J. Lucendo, 12,13 Stephan Miehlke, 14 Salvatore Oliva, 15 Christoph Schlag, 2 Alain Schoepfer, 16 Alex Straumann, 2 Michael Vieth, 17 and Albert J. Bredenoord, 18 on behalf of EUREOS and TIGERs
doi : 10.1016/j.cgh.2022.12.018
Volume 21, Issue 10, September 2023, Pages 2526-2533
A Newly Proposed Severity Index for Eosinophilic Esophagitis is Associated With Baseline Clinical Features and Successful Treatment Response
Cary C. Cotton,1 Susan E. Moist, 1 Sarah J. McGee, 1 Glenn T. Furuta, 2 Seema S. Aceves, 3 and Evan S. Dellon
doi : 10.1016/j.cgh.2023.03.047
Volume 21, Issue 10, September 2023, Pages 2534-2542.e1
A Protocolized Management of Walled-Off Necrosis (WON) Reduces Time to WON Resolution and Improves Outcomes
Serge Baroud, 1 Vinay Chandrasekhara, 2 Andrew C. Storm, 2 Ryan J. Law, 2 Eric J. Vargas, 2 Michael J. Levy,2 Tala Mahmoud, 2 Fateh Bazerbachi, 3 Aliana Bofill-Garcia, 2 Rabih Ghazi, 2 Daniel B. Maselli, 2 John A. Martin, 2 Santhi Swaroop Vege, 2 Naoki Takahashi, 4 Bret T. Petersen, 2 Mark D. Topazian, 2 and Barham K. Abu Dayyeh
doi : 10.1016/j.cgh.2023.04.029
Volume 21, Issue 10, September 2023, Pages 2543-2550.e1
Diagnostic Value of Adding Magnifying Chromoendoscopy to Magnifying Narrow-Band Imaging Endoscopy for Colorectal Polyps
Tomoaki Matsumura, 1 Alanna Ebigbo, 2 Christoph R?mmele, 2 Hiroaki Ikematsu, 3 Hideaki Ishigami, 4 Takuto Suzuki, 5 Hideaki Harada, 6 Tomoyuki Yada, 7 Yusaku Takatori, 8 Manabu Takeuchi,9 Kenichiro Okimoto, 1 Naoki Akizue, 1 Daisuke Maruoka, 1 Yoshiyasu Kitagawa, 5 Tatsunori Minamide, 3 Tomoyuki Iwaki, 6 Yuji Amano, 6 Keisuke Matsusaka, 10 Kengo Nagashima, 11 Tadateru Maehata, 8 Naohisa Yahagi, 8 Helmut Messmann,2 and Naoya Kato 1
doi : 10.1016/j.cgh.2023.01.028
Volume 21, Issue 10, September 2023, Pages 2551-2559.e2
The Spectrum and Impact of Metabolic Dysfunction in MAFLD: A Longitudinal Cohort Analysis of 32,683 Overweight and Obese Individuals
Kai En Chan, 1, * Cheng Han Ng, 1, * Clarissa Elysia Fu, 1 Jingxuan Quek,1 Gwyneth Kong, 1 Yi Jie Goh, 2 Rebecca Wenling Zeng, 1 Michael Tseng, 3 Manik Aggarwal, 4 Benjamin Nah, 2 Douglas Chee, 2 Zhen Yu Wong, 5 Sitong Zhang, 6,7 Jiong-Wei Wang, 6,7 Nicholas W. S. Chew, 1,8 Yock Young Dan, 1,2,9 Mohammad Shadab Siddiqui, 3 Mazen Noureddin, 10 Arun J. Sanyal, 3,§ and Mark Muthiah
doi : 10.1016/j.cgh.2022.09.028
Volume 21, Issue 10, September 2023, Pages 2560-2569.e15
MRI-AST (MAST) Score Accurately Predicts Major Adverse Liver Outcome, Hepatocellular Carcinoma, Liver Transplant, and Liver-Related Death
Emily Truong, 1 Jeffrey A. Gornbein, 2 Ju Dong Yang, 3,4 Nabil Noureddin, 5 Stephen A. Harrison, 6 Naim Alkhouri, 7 and Mazen Noureddin
doi : 10.1016/j.cgh.2023.02.003
Volume 21, Issue 10, September 2023, Pages 2570-2577.e1
Association of HSD17B13 and PNPLA3 With Liver Enzymes and Fibrosis in Hispanic/Latino Individuals of Diverse Genetic Ancestries
Stephanie M. Rutledge, 1,2 Emily R. Soper, 3,4 Ning Ma, 5 Vikas Pejaver, 3,6 Scott L. Friedman, 5 Andrea D. Branch, 5 Eimear E. Kenny, 3,6,7 Gillian M. Belbin, 3,7 and Noura S. Abul-Husn
doi : 10.1016/j.cgh.2022.12.025
Volume 21, Issue 10, September 2023, Pages 2578-2587.e11
Nonalcoholic Fatty Liver Disease Is Independently Associated With Higher All-Cause and Cause-Specific Mortality
Leyla de Avila, 1 Linda Henry, 3 James M. Paik, 1,2 Naila Ijaz, 4 Ali A. Weinstein, 2 and Zobair M. Younossi
doi : 10.1016/j.cgh.2023.01.006
Volume 21, Issue 10, September 2023, Pages 2588-2596.e3
Saroglitazar, a Dual PPAR α/γ Agonist, Improves Atherogenic Dyslipidemia in Patients With Non-Cirrhotic Nonalcoholic Fatty Liver Disease: A Pooled Analysis
Mohammad Shadab Siddiqui, 1, * Deven Parmar, 2, * Farheen Sheikh, 2 Shiv Kumar Sarin, 3 Laura Cisneros, 4 Samer Gawrieh, 5 Taufik Momin, 2 Ajay Duseja, 6 and Arun J. Sanyal
doi : 10.1016/j.cgh.2023.01.018
Volume 21, Issue 10, September 2023, Pages 2597-2605.e2
Racial and Ethnic Disparities in Characteristics and Care Patterns of Chronic Hepatitis B Patients in the United States
Joanne K. Liu, 1,2 Leslie Y. Kam, 2 Daniel Q. Huang, 3,4 Linda Henry, 2 Ramsey Cheung, 2,5 and Mindie H. Nguyen 2,6
doi : 10.1016/j.cgh.2023.01.035
Volume 21, Issue 10, September 2023, Pages 2606-2615.e7
Oral Ritlecitinib and Brepocitinib for Moderate-to-Severe Ulcerative Colitis: Results From a Randomized, Phase 2b Study
William J. Sandborn, 1 Silvio Danese, 2 Jaroslaw Leszczyszyn, 3 Jacek Romatowski, 4 Engin Altintas, 5 Elena Peeva, 6 Mina Hassan-Zahraee, 7 Michael S. Vincent, 7 Padmalatha S. Reddy, 7 Christopher Banfield, 7 Mikhail Salganik, 7 Anindita Banerjee, 7 Jeremy D. Gale, 7 and Kenneth E. Hung
doi : 10.1016/j.cgh.2022.12.029
Volume 21, Issue 10, September 2023, Pages 2616-2628.e7
Second–Line Biologic Therapy Following Tumor Necrosis Factor Antagonist Failure: A Real–World Propensity Score–Weighted Analysis
Susanne Ibing, 1,2 Judy H. Cho, 3 Erwin P. B?ttinger, 1,2 and Ryan C. Ungaro
doi : 10.1016/j.cgh.2023.01.038
Volume 21, Issue 10, September 2023, Pages 2629-2638
Incidence, Management, and Outcomes of Very Early Onset Inflammatory Bowel Diseases and Infantile-Onset Disease: An Epi-IIRN Study
Ohad Atia, 1 Eric I. Benchimol, 2,3 Natan Ledderman, 4 Shira Greenfeld, 5,6 Revital Kariv, 5,6 Yiska Loewenberg Weisband,7 Eran Matz, 8 Jacob Ollech, 6,9 Iris Dotan, 6,9 Amit Assa, 1 Dror S. Shouval, 6,10 Holm H. Uhlig, 11 Aleixo M. Muise, 2 Ola Olén, 12,13 M. Ellen Kuenzig, 2,3 Gilaad G. Kaplan, 14 and Dan Turner
doi : 10.1016/j.cgh.2022.10.026
Volume 21, Issue 10, September 2023, Pages 2639-2648.e6
Associations of Antibiotics, Hormonal Therapies, Oral Contraceptives, and Long-Term NSAIDS With Inflammatory Bowel Disease: Results From the Prospective Urban Rural Epidemiology (PURE) Study
Neeraj Narula, 1,2 Emily C. L. Wong, 1 Cara Pray, 1 John K. Marshall, 1 Sumathy Rangarajan, 2 Shofiqul Islam, 2 Ahmad Bahonar, 3 Khalid F. Alhabib, 4 Anna Kontsevaya, 5 Farnaza Ariffin, 6 Homer U. Co, 7 Wadeia Al Sharief,8 Andrzej Szuba, 9 Andreas Wielgosz, 10 Maria Luz Diaz, 11 Rita Yusuf, 12 Lanthé Kruger, 13 Biju Soman, 14 Yang Li,15 Chuangshi Wang, 15 Lu Yin, 15 Erkin Mirrakhimov, 16 Fernando Lanas, 17 Kairat Davletov, 18 Annika Rosengren, 19 Patricio Lopez-Jaramillo, 20 Rasha Khatib, 21,22 Aytekin Oguz,23 Romaina Iqbal, 24 Karen Yeates, 25 ?lvaro Avezum, 26 Walter Reinisch,27 Paul Moayyedi, 1,2 and Salim Yusuf
doi : 10.1016/j.cgh.2022.11.037
Volume 21, Issue 10, September 2023, Pages 2649-2659.e16
The Socioeconomic Impact of Irritable Bowel Syndrome: An Analysis of Direct and Indirect Health Care Costs
Michelle H. M. A. Bosman, 1,2, * Zsa Zsa R. M. Weerts, 1,2, * Johanna T. W. Snijkers, 1,2 Lisa Vork, 1,2 Zlatan Mujagic, 1,2 Ad A. M. Masclee, 1,2 Daisy M. A. E. Jonkers, 1,2 and Daniel Keszthelyi
doi : 10.1016/j.cgh.2023.01.017
Volume 21, Issue 10, September 2023, Pages 2660-2669
Misdiagnosis of Gastroparesis is Common: A Retrospective Review of Patients Referred to a Tertiary Gastroenterology Practice
DAVID J. CANGEMI LILLY STEPHENS BRIAN E. LACY
doi : 10.1016/j.cgh.2023.01.024
Volume 21, Issue 10, September 2023, Pages 2670-2672.e3
Heightened Risk for Gastric Cancer Among Immigrant Populations in New York State From High-Incidence Countries
doi : 10.1016/j.cgh.2022.08.008
Volume 21, Issue 10, September 2023, Pages 2673-2675.e3
Serum Amylase as a Biomarker for Proof-of-Concept Studies in Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis Prevention
doi : 10.1016/j.cgh.2022.08.020
Volume 21, Issue 10, September 2023, Pages 2676-2678.e2
Maternal Exposure to Anti-TNF or Thiopurines for IBD Does Not Increase Risk of Early-life Malignancy in Children
doi : 10.1016/j.cgh.2022.08.028
Volume 21, Issue 10, September 2023, Pages 2679-2681.e5
Clinical Utility of Combined MRI-PDFF and ALT Response in Predicting Histologic Response in Nonalcoholic Fatty Liver Disease
doi : 10.1016/j.cgh.2022.08.036
Volume 21, Issue 10, September 2023, Pages 2682-2685.e4
Frequent Abnormal Pancreas Imaging in Patients With Pathogenic ATM, BRCA1, BRCA2, and PALB2 Breast Cancer Susceptibility Variants
doi : 10.1016/j.cgh.2022.08.040
Volume 21, Issue 10, September 2023, Pages 2686-2688.e2
Minimal Risk of Hepatocellular Carcinoma in Noncirrhotic Budd-Chiari Syndrome: A Three-Decade Population-Based Study
doi : 10.1016/j.cgh.2022.08.042
Volume 21, Issue 10, September 2023, Pages 2689-2691.e1
Leveraging a New ICD-10 Diagnosis Code to Characterize Hospitalized Patients With Primary Sclerosing Cholangitis
doi : 10.1016/j.cgh.2022.09.001
Volume 21, Issue 10, September 2023, Pages 2692-2694
Cost-Benefit Analysis of Hydrogen Breath Test–Directed Rifaximin for Treatment of Diarrhea-Predominant Irritable Bowel Syndrome
doi : 10.1016/j.cgh.2022.09.010
Volume 21, Issue 10, September 2023, Pages 2695-2696.e1
Exam 1: Mortality and Liver-Related Events in Lean Versus Non-Lean Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis
doi : 10.1016/j.cgh.2023.06.022
Volume 21, Issue 10, September 2023, Pages e29-e30
Exam 2: Dietary Interventions for the Treatment of Inflammatory Bowel Diseases: An Updated Systematic Review and Meta-analysis
doi : 10.1016/j.cgh.2023.06.019
Volume 21, Issue 10, September 2023, Pages e31-e32
Letter to the Editor: Intensive Lifestyle Management Improves Steatosis and Fibrosis in Pediatric Nonalcoholic Fatty Liver Disease
doi : /10.1016/j.cgh.2022.11.008
Volume 21, Issue 10, September 2023, Pages 2697-2698
The Time is Ripe for a Randomized Controlled Trial of Oral Vancomycin in Primary Sclerosing Cholangitis
doi : 10.1016/j.cgh.2022.11.017
Volume 21, Issue 10, September 2023, Pages 2699-2700
Regarding “Linked-color Imaging Detects More Colorectal Adenoma and Serrated Lesions: An International Randomized Controlled Trial�
doi : 10.1016/j.cgh.2022.12.003
Volume 21, Issue 10, September 2023, Page 2701
Comments on Association of Chronic Pancreatitis Pain Features With Physical, Mental, and Social Health
doi : 10.1016/j.cgh.2022.12.015
Volume 21, Issue 10, September 2023, Pages 2702-2703
Nonalcoholic Steatohepatitis Decompensation and Portal Pressures
doi : 10.1016/j.cgh.2022.12.031
Volume 21, Issue 10, September 2023, Page 2704
Cardiovascular and Liver Diseases in Subjects With Sarcopenic Obesity and Nonalcoholic Fatty Liver Disease
doi : 10.1016/j.cgh.2023.02.010
Volume 21, Issue 10, September 2023, Pages 2704-2705
